Oral Decitabine/cedazuridine is an Effective Ambulatory Therapy for Patients with Myelofibrosis Refractory to JAK2 Inhibitor Therapy
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2024）
关键词
MPN-accelerated phase,Hypomethylating agent,Ruxolitinib-refractory,myeloproliferative neoplasms,Chromatin-modifying agent
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要